175 related articles for article (PubMed ID: 15665043)
1. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta.
Faffe DS; Flynt L; Mellema M; Whitehead TR; Bourgeois K; Panettieri RA; Silverman ES; Shore SA
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1040-8. PubMed ID: 15665043
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13.
Faffe DS; Flynt L; Mellema M; Moore PE; Silverman ES; Subramaniam V; Jones MR; Mizgerd JP; Whitehead T; Imrich A; Panettieri RA; Shore SA
J Allergy Clin Immunol; 2005 Mar; 115(3):514-20. PubMed ID: 15753898
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells.
Lahiri T; Laporte JD; Moore PE; Panettieri RA; Shore SA
Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1225-32. PubMed ID: 11350802
[TBL] [Abstract][Full Text] [Related]
4. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells : synergy with interleukin-1beta.
Bernard C; Merval R; Lebret M; Delerive P; Dusanter-Fourt I; Lehoux S; Créminon C; Staels B; Maclouf J; Tedgui A
Circ Res; 1999 Dec 3-17; 85(12):1124-31. PubMed ID: 10590238
[TBL] [Abstract][Full Text] [Related]
7. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells.
Schnittker D; Kwofie K; Ashkar A; Trigatti B; Richards CD
Mediators Inflamm; 2013; 2013():317503. PubMed ID: 24307759
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
Weiss TW; Speidl WS; Kaun C; Rega G; Springer C; Macfelda K; Losert UM; Grant SL; Marro ML; Rhodes AD; Fuernkranz A; Bialy J; Ullrich R; Holzmann P; Pacher R; Maurer G; Huber K; Wojta J
Cardiovasc Res; 2003 Sep; 59(3):628-38. PubMed ID: 14499864
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
Repovic P; Fears CY; Gladson CL; Benveniste EN
Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro.
Langdon C; Leith J; Smith F; Richards CD
Arthritis Rheum; 1997 Dec; 40(12):2139-46. PubMed ID: 9416850
[TBL] [Abstract][Full Text] [Related]
18. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
Wuyts WA; Vanaudenaerde BM; Dupont LJ; Demedts MG; Verleden GM
Respir Med; 2003 Jul; 97(7):811-7. PubMed ID: 12854631
[TBL] [Abstract][Full Text] [Related]
20. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.
Hurst SM; McLoughlin RM; Monslow J; Owens S; Morgan L; Fuller GM; Topley N; Jones SA
J Immunol; 2002 Nov; 169(9):5244-51. PubMed ID: 12391243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
